乳腺癌的血管生成 - Suppr

Suppr

超能文献

Angiogenesis of breast cancer.

作者信息

Schneider Bryan P, Miller Kathy D

机构信息

Division of Hematology-Oncology, Indiana University, 535 Barnhill Dr, RT-473 Indianapolis, IN 46202, USA.

出版信息

J Clin Oncol. 2005 Mar 10;23(8):1782-90. doi: 10.1200/JCO.2005.12.017.

DOI:10.1200/JCO.2005.12.017

PMID:15755986

Abstract

摘要

相似文献

Angiogenesis of breast cancer.

J Clin Oncol. 2005 Mar 10;23(8):1782-90. doi: 10.1200/JCO.2005.12.017.

Breast tumour angiogenesis.

Breast Cancer Res. 2007;9(6):216. doi: 10.1186/bcr1796.

Bevacizumab for advanced breast cancer.

Hematol Oncol Clin North Am. 2007 Apr;21(2):303-19. doi: 10.1016/j.hoc.2007.03.006.

Antiangiogenic agents in breast cancer.

Cancer Invest. 2007 Oct;25(7):518-26. doi: 10.1080/07357900701648516.

Angiogenesis as a strategic target for ovarian cancer therapy.

Nat Clin Pract Oncol. 2008 Apr;5(4):194-204. doi: 10.1038/ncponc1051. Epub 2008 Feb 12.

[Role of angiogenesis inhibitors in the treatment of colorectal cancer].

Magy Onkol. 2007;51(2):139-44. Epub 2007 Jul 29.

[Angiogenesis and breast cancer].

Bull Cancer. 2007 Jul;94 Spec No:S203-10.

The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab.

Eur J Cancer. 2008 May;44(7):912-20. doi: 10.1016/j.ejca.2008.01.005. Epub 2008 Apr 7.

[Inhibition of angiogenesis by proteins, peptides and "small molecules"].

Onkologie. 2005 Oct;28 Suppl 4:29-34. doi: 10.1159/000088826. Epub 2005 Oct 3.

Vascular normalization: study examines how antiangiogenesis therapies work.

J Natl Cancer Inst. 2005 Mar 2;97(5):336-7. doi: 10.1093/jnci/97.5.336.

引用本文的文献

Continuous Anlotinib Combined with Oral Vinorelbine has Shown Anti-Tumor Efficiency in Refractory HER2 Negative Advanced Breast Cancer.

Breast Cancer (Dove Med Press). 2025 Jun 28;17:545-555. doi: 10.2147/BCTT.S534082. eCollection 2025.

Panoramic photoacoustic computed tomography with learning-based classification enhances breast lesion characterization.

Nat Biomed Eng. 2025 Jun 24. doi: 10.1038/s41551-025-01435-3.

CPT1A/HIF-1α positive feedback loop induced fatty acid oxidation metabolic pathway contributes to the L-ascorbic acid-driven angiogenesis in breast cancer.

Breast Cancer Res. 2025 May 12;27(1):74. doi: 10.1186/s13058-025-02039-0.

Comparative analysis of diagnostic performance of automatic breast ultrasound and spectral mammography as complementary methods to mammography examination.

Pol J Radiol. 2025 Feb 3;90:e55-e65. doi: 10.5114/pjr/199755. eCollection 2025.

Factors Influencing Background Parenchymal Enhancement in Contrast-Enhanced Mammography Images.

Diagnostics (Basel). 2024 Oct 8;14(19):2239. doi: 10.3390/diagnostics14192239.

Ultrasound-Based Noncontrast Microvascular Imaging for Evaluation of Breast Lesions: Imaging Techniques and Review of Diagnostic Criteria.

Indian J Radiol Imaging. 2024 Mar 17;34(4):702-713. doi: 10.1055/s-0044-1782162. eCollection 2024 Oct.

Current status and future perspectives of contrast-enhanced ultrasound diagnosis of breast lesions.

J Med Ultrason (2001). 2024 Oct;51(4):611-625. doi: 10.1007/s10396-024-01486-0. Epub 2024 Aug 23.

Breast multiparametric ultrasound: a single-center experience.

J Ultrasound. 2024 Dec;27(4):831-839. doi: 10.1007/s40477-024-00944-2. Epub 2024 Aug 5.

Differentiating between benign and malignant breast lesions using dual-energy CT-based model: development and validation.

Insights Imaging. 2024 Jul 10;15(1):173. doi: 10.1186/s13244-024-01752-2.

The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer.

Cancer Med. 2024 Apr;13(8):e7181. doi: 10.1002/cam4.7181.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Angiogenesis of breast cancer.

作者信息

Schneider Bryan P, Miller Kathy D

机构信息

Division of Hematology-Oncology, Indiana University, 535 Barnhill Dr, RT-473 Indianapolis, IN 46202, USA.

出版信息

J Clin Oncol. 2005 Mar 10;23(8):1782-90. doi: 10.1200/JCO.2005.12.017.

DOI:10.1200/JCO.2005.12.017

PMID:15755986

Abstract

摘要

相似文献

Angiogenesis of breast cancer.

J Clin Oncol. 2005 Mar 10;23(8):1782-90. doi: 10.1200/JCO.2005.12.017.

Breast tumour angiogenesis.

Breast Cancer Res. 2007;9(6):216. doi: 10.1186/bcr1796.

Bevacizumab for advanced breast cancer.

Hematol Oncol Clin North Am. 2007 Apr;21(2):303-19. doi: 10.1016/j.hoc.2007.03.006.

Antiangiogenic agents in breast cancer.

Cancer Invest. 2007 Oct;25(7):518-26. doi: 10.1080/07357900701648516.

Angiogenesis as a strategic target for ovarian cancer therapy.

Nat Clin Pract Oncol. 2008 Apr;5(4):194-204. doi: 10.1038/ncponc1051. Epub 2008 Feb 12.

[Role of angiogenesis inhibitors in the treatment of colorectal cancer].

Magy Onkol. 2007;51(2):139-44. Epub 2007 Jul 29.

[Angiogenesis and breast cancer].

Bull Cancer. 2007 Jul;94 Spec No:S203-10.

The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab.

Eur J Cancer. 2008 May;44(7):912-20. doi: 10.1016/j.ejca.2008.01.005. Epub 2008 Apr 7.

[Inhibition of angiogenesis by proteins, peptides and "small molecules"].

Onkologie. 2005 Oct;28 Suppl 4:29-34. doi: 10.1159/000088826. Epub 2005 Oct 3.

Vascular normalization: study examines how antiangiogenesis therapies work.

J Natl Cancer Inst. 2005 Mar 2;97(5):336-7. doi: 10.1093/jnci/97.5.336.

引用本文的文献

Continuous Anlotinib Combined with Oral Vinorelbine has Shown Anti-Tumor Efficiency in Refractory HER2 Negative Advanced Breast Cancer.

Breast Cancer (Dove Med Press). 2025 Jun 28;17:545-555. doi: 10.2147/BCTT.S534082. eCollection 2025.

Panoramic photoacoustic computed tomography with learning-based classification enhances breast lesion characterization.

Nat Biomed Eng. 2025 Jun 24. doi: 10.1038/s41551-025-01435-3.

CPT1A/HIF-1α positive feedback loop induced fatty acid oxidation metabolic pathway contributes to the L-ascorbic acid-driven angiogenesis in breast cancer.

Breast Cancer Res. 2025 May 12;27(1):74. doi: 10.1186/s13058-025-02039-0.

Comparative analysis of diagnostic performance of automatic breast ultrasound and spectral mammography as complementary methods to mammography examination.

Pol J Radiol. 2025 Feb 3;90:e55-e65. doi: 10.5114/pjr/199755. eCollection 2025.

Factors Influencing Background Parenchymal Enhancement in Contrast-Enhanced Mammography Images.

Diagnostics (Basel). 2024 Oct 8;14(19):2239. doi: 10.3390/diagnostics14192239.

Ultrasound-Based Noncontrast Microvascular Imaging for Evaluation of Breast Lesions: Imaging Techniques and Review of Diagnostic Criteria.

Indian J Radiol Imaging. 2024 Mar 17;34(4):702-713. doi: 10.1055/s-0044-1782162. eCollection 2024 Oct.

Current status and future perspectives of contrast-enhanced ultrasound diagnosis of breast lesions.

J Med Ultrason (2001). 2024 Oct;51(4):611-625. doi: 10.1007/s10396-024-01486-0. Epub 2024 Aug 23.

Breast multiparametric ultrasound: a single-center experience.

J Ultrasound. 2024 Dec;27(4):831-839. doi: 10.1007/s40477-024-00944-2. Epub 2024 Aug 5.

Differentiating between benign and malignant breast lesions using dual-energy CT-based model: development and validation.

Insights Imaging. 2024 Jul 10;15(1):173. doi: 10.1186/s13244-024-01752-2.

The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer.

Cancer Med. 2024 Apr;13(8):e7181. doi: 10.1002/cam4.7181.